COVID-19 Case Surveillance Public Use Data

Beginning March 1, 2022, the "COVID-19 Case Surveillance Public Use Data" will be updated on a monthly basis.

This case surveillance public use dataset has 12 elements for all COVID-19 cases shared with CDC and includes demographics, any exposure history, disease severity indicators and outcomes, presence of any underlying medical conditions and risk behaviors, and no geographic data.

CDC has three COVID-19 case surveillance datasets:

  • COVID-19 Case Surveillance Public Use Data with Geography: Public use, patient-level dataset with clinical data (including symptoms), demographics, and county and state of residence. (19 data elements)
  • COVID-19 Case Surveillance Public Use Data: Public use, patient-level dataset with clinical and symptom data and demographics, with no geographic data. (12 data elements)
  • COVID-19 Case Surveillance Restricted Access Detailed Data: Restricted access, patient-level dataset with clinical and symptom data, demographics, and state and county of residence. Access requires a registration process and a data use agreement. (32 data elements)

The following apply to all three datasets:

  • Data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf.
  • Data are considered provisional by CDC and are subject to change until the data are reconciled and verified with the state and territorial data providers.
  • Some data cells are suppressed to protect individual privacy.
  • The datasets will include all cases with the earliest date available in each record (date received by CDC or date related to illness/specimen collection) at least 14 days prior to the creation of the previously updated datasets. This 14-day lag allows case reporting to be stabilized and ensures that time-dependent outcome data are accurately captured.
  • Datasets are updated monthly.
  • Datasets are created using CDC’s operational Policy on Public Health Research and Nonresearch Data Management and Access and include protections designed to protect individual privacy.
  • For more information about data collection and reporting, please see https://wwwn.cdc.gov/nndss/data-collection.html
  • For more information about the COVID-19 case surveillance data, please see https://www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html

Overview

The COVID-19 case surveillance database includes individual-level data reported to U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and affiliates. On April 5, 2020, COVID-19 was added to the Nationally Notifiable Condition List and classified as “immediately notifiable, urgent (within 24 hours)” by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (Interim-20-ID-01). CSTE updated the position statement on August 5, 2020 to clarify the interpretation of antigen detection tests and serologic test results within the case classification. The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC. COVID-19 case surveillance data are collected by jurisdictions and reported volun

Data e Risorse

Campo Valore
accessLevel public
accrualPeriodicity R/P2W
bureauCode {009:20}
catalog_@context https://project-open-data.cio.gov/v1.1/schema/catalog.jsonld
catalog_@id https://healthdata.gov/data.json
catalog_conformsTo https://project-open-data.cio.gov/v1.1/schema
catalog_describedBy https://project-open-data.cio.gov/v1.1/schema/catalog.json
describedBy https://data.cdc.gov/api/views/vbim-akqf/files/0eb0e326-d1bd-42a3-a748-acc6d6663326?download=true&filename=data_dictionary_covid_cases_public.xlsx
describedByType application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
identifier https://data.cdc.gov/api/views/vbim-akqf
issued 2020-05-15
landingPage https://data.cdc.gov/d/vbim-akqf
license https://www.usa.gov/government-works
modified 2022-03-03
old-spatial US
programCode {009:020}
publisher Centers for Disease Control and Prevention
references {https://github.com/CDCgov/covid_case_privacy_review/blob/master/analysis/utility_summary_public.pdf}
resource-type Dataset
source_datajson_identifier true
source_hash ad74ef294038467e3e197c2333004326d432bded
source_schema_version 1.1
spatial {"type":"Polygon","coordinates":[[[-124.733253,24.544245],[-124.733253,49.388611],[-66.954811,49.388611],[-66.954811,24.544245],[-124.733253,24.544245]]]}
temporal 2020-01-01/2022-02-28
theme {"Case Surveillance"}
Gruppi
  • AmeriGEOSS
  • National Provider
  • North America
Tag
  • amerigeo
  • amerigeoss
  • cases
  • ckan
  • coronavirus
  • covid
  • covid-19
  • covid19
  • geo
  • geoss
  • national
  • north-america
  • surveillance
  • united-states
isopen False
license_id other-license-specified
license_title other-license-specified
maintainer Surveillance Review and Response Group
maintainer_email eocevent394@cdc.gov
metadata_created 2025-11-22T00:44:59.308265
metadata_modified 2025-11-22T00:44:59.308269
notes <b>Beginning March 1, 2022, the "COVID-19 Case Surveillance Public Use Data" will be updated on a monthly basis.</b> This case surveillance public use dataset has 12 elements for all COVID-19 cases shared with CDC and includes demographics, any exposure history, disease severity indicators and outcomes, presence of any underlying medical conditions and risk behaviors, and no geographic data. <br> <h4><b>CDC has three COVID-19 case surveillance datasets:</b></h4> - <a href="https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Public-Use-Data-with-Ge/n8mc-b4w4">COVID-19 Case Surveillance Public Use Data with Geography</a>: Public use, patient-level dataset with clinical data (including symptoms), demographics, and county and state of residence. (19 data elements) <br> - <a href="https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Public-Use-Data/vbim-akqf">COVID-19 Case Surveillance Public Use Data</a>: Public use, patient-level dataset with clinical and symptom data and demographics, with no geographic data. (12 data elements)<br> - <a href="https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Restricted-Access-Detai/mbd7-r32t">COVID-19 Case Surveillance Restricted Access Detailed Data</a>: Restricted access, patient-level dataset with clinical and symptom data, demographics, and state and county of residence. Access requires a registration process and a data use agreement. (32 data elements) The following apply to all three datasets: - Data elements can be found on the COVID-19 case report form located at <a href="https://www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf">www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf</a>.<br> - Data are considered provisional by CDC and are subject to change until the data are reconciled and verified with the state and territorial data providers. - Some data cells are suppressed to protect individual privacy.<br> - The datasets will include all cases with the earliest date available in each record (date received by CDC or date related to illness/specimen collection) at least 14 days prior to the creation of the previously updated datasets. This 14-day lag allows case reporting to be stabilized and ensures that time-dependent outcome data are accurately captured.<br> - Datasets are updated monthly. <br> - Datasets are created using CDC’s operational Policy on Public Health Research and Nonresearch Data Management and Access and include protections designed to protect individual privacy.<br> - For more information about data collection and reporting, please see <a href="https://wwwn.cdc.gov/nndss/data-collection.html"> https://wwwn.cdc.gov/nndss/data-collection.html</a><br> - For more information about the COVID-19 case surveillance data, please see <a href="https://www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html"> https://www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html</a><br> <h4><b>Overview</b></h4> The COVID-19 case surveillance database includes individual-level data reported to U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and affiliates. On April 5, 2020, COVID-19 was added to the <a href="https://wwwn.cdc.gov/nndss/conditions/"> Nationally Notifiable Condition List </a> and classified as “immediately notifiable, urgent (within 24 hours)” by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (Interim-20-ID-01). CSTE updated the position statement on August 5, 2020 to clarify the interpretation of antigen detection tests and serologic test results within the case classification. The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC. COVID-19 case surveillance data are collected by jurisdictions and reported volun
num_resources 4
num_tags 14
title COVID-19 Case Surveillance Public Use Data